![MedPage Today](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/262/normal/Screen_Shot_2016-02-09_at_10.51.03.png?1455015082)
Trastuzumab Biosimilar Equivalent in Early HER2+ Breast CA Tx
MedPage Today,
Action Points Efficacy, safety, and immunogenicity were comparable between SB3, a Korean-manufactured biosimilar to trastuzumab …
Action Points Efficacy, safety, and immunogenicity were comparable between SB3, a Korean-manufactured biosimilar to trastuzumab …
The importance of these findings cannot be underscored sufficiently. The development of a biosimilar for treatment in this…